Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma Meeting Abstract


Authors: Ludwig, J. A.; Federman, N.; Anderson, P.; Macy, M. E.; Davis, L. E.; Riedel, R. F.; Muscal, J. A.; Daw, N. C.; Ratan, R.; Toretsky, J.; Ianopulos, X.; Hsu, F. J.; Breitmeyer, J. B.; Meyers, P.
Abstract Title: Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S972
Language: English
ACCESSION: WOS:000573469102207
DOI: 10.1016/j.annonc.2020.08.1846
PROVIDER: wos
Notes: Meeting Abstract: 1620O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Meyers
    311 Meyers